Fluconazole indications and usage: Difference between revisions
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{Fluconazole}} {{CMG}}; {{AE}} {{AZ}} ==Indications And Usage== ===Treatment==== *'''Vaginal candidiasis''' (vaginal yeast infections due to Candida). *'''Oroph..." |
|||
| Line 5: | Line 5: | ||
==Indications And Usage== | ==Indications And Usage== | ||
===Treatment | ===Treatment=== | ||
*'''Vaginal candidiasis''' (vaginal yeast infections due to Candida). | *'''Vaginal candidiasis''' (vaginal yeast infections due to Candida). | ||
Latest revision as of 19:29, 17 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Indications And Usage
Treatment
- Vaginal candidiasis (vaginal yeast infections due to Candida).
- Oropharyngeal and esophageal candidiasis.
In open noncomparative studies of relatively small numbers of patients, DIFLUCAN was also effective for the treatment of Candida urinary tract infections, peritonitis, and systemic Candida infections including candidemia, disseminated candidiasis, and pneumonia. Cryptococcal meningitis. Before prescribing DIFLUCAN (fluconazole) for AIDS patients with cryptococcal meningitis, please see CLINICAL STUDIES section. Studies comparing DIFLUCAN to amphotericin B in non-HIV infected patients have not been conducted.
Prophylaxis
DIFLUCAN is also indicated to decrease the incidence of candidiasis in patients undergoing bone marrow transplantation who receive cytotoxic chemotherapy and/or radiation therapy.
Specimens for fungal culture and other relevant laboratory studies (serology, histopathology) should be obtained prior to therapy to isolate and identify causative organisms. Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly.[1]
References
Adapted from the FDA Package Insert.